Black Diamond Therapeutics, Inc.BDTXNASDAQ
Loading
Stockholders Equity Over TimeExpanding
Percentile Rank50
3Y CAGR-1.0%
5Y CAGR-18.3%
Year-over-Year Change
Net worth of the company (assets minus liabilities)
3Y CAGR
-1.0%/yr
Annual compound
5Y CAGR
-18.3%/yr
Recent acceleration
Percentile
P50
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $112.21M | +34.7% |
| 2024 | $83.28M | -28.7% |
| 2023 | $116.74M | +0.9% |
| 2022 | $115.69M | -40.9% |
| 2021 | $195.90M | -36.3% |
| 2020 | $307.76M | +752.6% |
| 2019 | $-47.16M | -203.4% |
| 2018 | $-15.54M | -132.8% |
| 2017 | $-6.67M | - |